Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T22:28:55.761Z.
Calculation as of: 2026-10-06T22:28:55.761Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 97452f2638ad5d60f1716ef7360feea6a822b872a50cf44a9ba771f9e60b5836
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Twist Bioscience Corporation
Market Cap
$10.40B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.31B
EV/EBITDA Ratio
10.62x
TTM Avg
14.91x
3Y Avg
21.91x
5Y Avg
22.70x
Market Cap
$10.24B
EV/EBITDA Ratio
N/A
TTM Avg
571.24x
3Y Avg
571.24x
5Y Avg
571.24x
Market Cap
$10.19B
EV/EBITDA Ratio
19.73x
TTM Avg
10.46x
3Y Avg
9.60x
5Y Avg
10.77x
Market Cap
$10.13B
EV/EBITDA Ratio
11.35x
TTM Avg
14.07x
3Y Avg
18.68x
5Y Avg
23.02x
Market Cap
$10.72B
EV/EBITDA Ratio
5.87x
TTM Avg
6.58x
3Y Avg
8.00x
5Y Avg
8.11x
Market Cap
$10.03B
EV/EBITDA Ratio
20.65x
TTM Avg
24.29x
3Y Avg
24.11x
5Y Avg
21.70x
Market Cap
$10.87B
EV/EBITDA Ratio
33.30x
TTM Avg
20.02x
3Y Avg
35.15x
5Y Avg
96.65x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Twist Bioscience Corporation (TWST) | $10.40B | N/A | N/A | N/A | N/A |
| Globus Medical, Inc. (GMED)vs › | $10.31B | 10.62x | 14.91x | 21.91x | 22.70x |
| 10x Genomics, Inc. (TXG)vs › | $10.24B | N/A | 571.24x | 571.24x | 571.24x |
| Molina Healthcare, Inc. (MOH)vs › | $10.19B | 19.73x | 10.46x | 9.60x | 10.77x |
| ImmunityBio, Inc. (IBRX)vs › | $10.15B | N/A | N/A | N/A | N/A |
| Align Technology, Inc. (ALGN)vs › | $10.13B | 11.35x | 14.07x | 18.68x | 23.02x |
| Universal Health Services, Inc. (UHS)vs › | $10.72B | 5.87x | 6.58x | 8.00x | 8.11x |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 20.65x | 24.29x | 24.11x | 21.70x |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.87B | 33.30x | 20.02x | 35.15x | 96.65x |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 27.75x | 22.29x | 19.89x | 21.49x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
